%0 Journal Article
%T Indian Academy of Pediatrics Consensus Guidelines for Probiotic Use in Childhood Diarrhea.
%A Yachha SK
%A Sarma MS
%A Mohan N
%A Wadhwa N
%A Kumar Vr N
%A Srinivasan R
%A Shah D
%A Soans S
%A Yewale V
%A Basavaraja GV
%A Parekh BJ
%A Yachha SK
%A Sarma MS
%A Mohan N
%A Wadhwa N
%A Kumar Vr N
%A Srinivasan R
%A Shah D
%A Soans S
%A Yewale V
%A Basavaraja GV
%A Parekh BJ
%J Indian Pediatr
%V 59
%N 7
%D Jul 2022 15
%M 35273131
%F 3.839
%X BACKGROUND: Several probiotic species and strains, single or combined, have been evaluated in childhood diarrheal disorders, and recommendations have ever been changing as newer trials are published. Therefore, there is a need to develop a guideline for Indian children describing the current role of probiotics in clinical practice.
OBJECTIVE: To develop a guideline for the use of probiotics in children with diarrhea.
METHODS: A national consultative group (NCG) was constituted by the Indian Academy of Pediatrics (IAP), consisting of subjects experts. Sub-topics were allotted to various experts as paired groups for detailed review. Members reviewed the international and Indian literature for existing guidelines, systematic reviews, meta-analyses and trials. Thereafter, two virtual structured meetings of the group were held on 2nd and 22nd August, 2020. The management guidelines were formulated by the group and circulated to the participants for comments. The final guidelines were approved by all experts, and adopted by the IAP executive board.
CONCLUSIONS: The NCG suggests Lactobacillus GG as a conditional recommendation with low-to-moderate level evidence or Saccharomyces boulardii as a conditional recommendation with very low-to-low level evidence as adjuvant therapy in acute diarrhea. The NCG also recommends the use of combination probiotics in neonatal necrotizing enterocolitis (NEC), as these reduce the risk of NEC stage II and above, late-onset sepsis, mortality and also time to achieve full feeds. The NCG does not recommend the use of any kind of probiotics in the therapy of acute dysentery, persistent diarrhea, Clostridium difficile diarrhea and chronic diarrheal conditions such as celiac disease, diarrhea-predominant irritable bowel syndrome and inflammatory bowel disease in children. Risk of antibiotic-associated diarrhea (AAD) is high with some antibiotics and most of these cases present as mild diarrhea. The NCG recommends probiotics only in special situations of AAD. L. rhamnoses GG or S. boulardii may be used for the prevention of AAD. VSL#3, a combination probiotic, may be used as an adjuvant in active pouchitis, prevention of recurrences and maintenance of remission in pouchitis.